# Arizona lab studies drug candidates for rare pediatric disorders

> An October 12 AWS report describes an eight-person laboratory at the University of Arizona College of Medicine–Phoenix researching existing drugs for rare neurodevelopmental disorders. The team derives RNA signatures from sequencing data and matches them against NIH datasets of approved compounds.

- Canonical URL: https://newsverum.com/en/news/university-arizona-rare-pediatric-drug-repurposing-2026
- Publisher: Newsverum
- Section: Technology
- Published: 2026-10-15T21:30:21+00:00
- Updated: 2026-10-15T21:30:21+00:00
- Source review period: 2026-10-12
- Other editions: [Türkçe](https://newsverum.com/tr/news/university-arizona-rare-pediatric-drug-repurposing-2026.md), [العربية](https://newsverum.com/ar/news/university-arizona-rare-pediatric-drug-repurposing-2026.md), [Français](https://newsverum.com/fr/news/university-arizona-rare-pediatric-drug-repurposing-2026.md), [Español](https://newsverum.com/es/news/university-arizona-rare-pediatric-drug-repurposing-2026.md), [Deutsch](https://newsverum.com/de/news/university-arizona-rare-pediatric-drug-repurposing-2026.md), [Português](https://newsverum.com/pt/news/university-arizona-rare-pediatric-drug-repurposing-2026.md)

*The source does not state the event date; the period shown is the source review period.*

The research pipeline combines four AWS services, including HealthOmics, SageMaker AI and Bedrock; researchers prioritize candidates with literature and models. AWS reports that the lab used Amazon Quick Research to cut one literature synthesis from hours of manual reading to 10–15 minutes. These remain research candidates; no clinically proven treatment was reported.

## Data

### Arizona lab studies drug candidates for rare pediatric disorders

Arizona lab studies drug candidates for rare pediatric disorders

Methodology: A source-reported technical account; not an independent experiment.

| date | label | description | status |
|---|---|---|---|
| 2026-10-12 | Source publication date | An October 12 AWS report describes an eight-person laboratory at the University of Arizona College of Medicine–Phoenix researching existing drugs for rare neurodevelopmental disorders. The team derives RNA signatures from sequencing data and matches them against NIH datasets of approved compounds. | occurred |

Sources: <https://aws.amazon.com/blogs/publicsector/university-of-arizona-researchers-accelerate-rare-pediatric-disease-drug-repurposing-with-aws/> · Download data: [JSON](https://newsverum.com/api/v1/articles/university-arizona-rare-pediatric-drug-repurposing-2026/data/reported-event?lang=en&format=json) · [CSV](https://newsverum.com/api/v1/articles/university-arizona-rare-pediatric-drug-repurposing-2026/data/reported-event?lang=en&format=csv)

## Sources

- [AWS Public Sector Blog](<https://aws.amazon.com/blogs/publicsector/university-of-arizona-researchers-accelerate-rare-pediatric-disease-drug-repurposing-with-aws/>) (Source checked: 2026-10-15; Published: 2026-10-12)

---

Cite the canonical URL above. [Editorial standards and corrections](https://newsverum.com/en/editorial)